company

NORDOVO BIOSCIENCES AS

0585 OSLO

Return on Equity
−35,37 %
Current Ratio
4,06
Debt-to-Equity Ratio
0,01
Key figures (NOK)2022
Revenue1 477 000
Net Income−4 198 000
Total Assets15 576 000
Total Equity11 868 000
Income (NOK)2022
Revenue1 477 000
Expenditure5 681 000
Operating Profit−4 203 000
Financial Income25 000
Financial Costs19 000
Financial Balance6 000
Earnings Before Tax−4 198 000
Tax0
Net Income−4 198 000
Balance (NOK)2022
Total Fixed Assets1 216 000
Total Current Assets14 360 000
Total Assets15 576 000
Total Retained Equity−8 321 000
Total Equity11 868 000
Total Long-Term Debt169 000
Total Current Debt3 540 000
Total Equity and Debt15 576 000
Cash flow (NOK)2022
Sales Income36 000
Other Income1 441 000
Revenue1 477 000
Cost of Goods Sold172 000
Salary Costs4 411 000
Depreciation59 000
Impairment0
Expenditure5 681 000
Operating Profit−4 203 000
Financial Income25 000
Financial Costs19 000
Financial Balance6 000
Dividends0
Net Income−4 198 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures1 024 000
Total Tangible Assets1 024 000
Total Fiancial Fixed Assets192 000
Total Fixed Assets1 216 000
Stock0
Total Investments0
Cash, Bank9 003 000
Total Current Assets14 360 000
Total Assets15 576 000
Total Equity11 868 000
Short-Term Group Debt0
Total Long-Term Debt169 000
Creditors1 160 000
Unpaid Taxes326 000
Dividends0
Other Current Debt2 053 000
Total Current Debt3 540 000
Total Equity and Debt15 576 000
Financial indicators2022
Return on Equity−35,37 %
Debt-to-Equity Ratio0,01
Operating Profit Margin−284,56 %
Current Ratio4,06
Quick Ratio4,06
Equity Ratio0,76
Gross Profit Margin88,35 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English